Zhongzhu Healthcare Holding Co.,Ltd (SHA:600568)
2.760
+0.020 (0.73%)
Feb 4, 2026, 11:29 AM CST
SHA:600568 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 562.78 | 513.55 | 628.98 | 495.73 | 569.85 | 717.02 |
Other Revenue | 7.84 | 7.84 | 9.59 | 10.24 | 11.21 | 10.45 |
| 570.62 | 521.39 | 638.56 | 505.97 | 581.06 | 727.47 | |
Revenue Growth (YoY) | -11.06% | -18.35% | 26.21% | -12.92% | -20.13% | 4.50% |
Cost of Revenue | 621.49 | 572.71 | 694.98 | 396.08 | 456.43 | 556.02 |
Gross Profit | -50.87 | -51.32 | -56.42 | 109.89 | 124.63 | 171.45 |
Selling, General & Admin | 143.74 | 187.12 | 205.2 | 190.65 | 188.5 | 174.57 |
Research & Development | 10.91 | 11.96 | 16.18 | 18.21 | 24.68 | 23.44 |
Other Operating Expenses | 10.67 | 14.8 | 57.87 | 109.29 | 9.83 | 6.19 |
Operating Expenses | 172.24 | 223.72 | 275.24 | 322.26 | 234.2 | 203.81 |
Operating Income | -223.11 | -275.04 | -331.66 | -212.37 | -109.57 | -32.35 |
Interest Expense | -8.45 | -0.94 | -7.45 | -15 | -15.85 | -4.98 |
Interest & Investment Income | - | 5.72 | 25.44 | 24.43 | 20.14 | 73.38 |
Currency Exchange Gain (Loss) | - | - | - | - | - | 0 |
Other Non Operating Income (Expenses) | -3.39 | -3.07 | -19.55 | -55.19 | -0.26 | -1.88 |
EBT Excluding Unusual Items | -234.95 | -273.33 | -333.22 | -258.13 | -105.55 | 34.17 |
Impairment of Goodwill | - | - | - | -26.73 | -68.7 | - |
Gain (Loss) on Sale of Investments | -323.43 | -333.77 | -5.61 | -248.67 | -3.28 | - |
Gain (Loss) on Sale of Assets | 1.23 | -0.38 | 26.01 | -0.66 | -2.67 | -0.2 |
Asset Writedown | -23.43 | -23.33 | -28.94 | -268.99 | -16.49 | -2.44 |
Legal Settlements | -0.64 | -0.64 | - | - | -0.45 | - |
Other Unusual Items | 9.94 | 4.15 | 3.37 | 1.83 | 9.69 | 10.96 |
Pretax Income | -571.27 | -627.3 | -338.4 | -801.34 | -187.45 | 42.49 |
Income Tax Expense | -6.51 | -2.13 | 0.02 | -9.56 | 21.06 | 27.9 |
Earnings From Continuing Operations | -564.76 | -625.17 | -338.41 | -791.78 | -208.51 | 14.59 |
Minority Interest in Earnings | 3.17 | 4.95 | -5.52 | -7.48 | -2.78 | -11.37 |
Net Income | -561.59 | -620.22 | -343.94 | -799.26 | -211.28 | 3.22 |
Net Income to Common | -561.59 | -620.22 | -343.94 | -799.26 | -211.28 | 3.22 |
Shares Outstanding (Basic) | 1,989 | 1,970 | 1,993 | 1,998 | 1,993 | 2,012 |
Shares Outstanding (Diluted) | 1,989 | 1,970 | 1,993 | 1,998 | 1,993 | 2,012 |
Shares Change (YoY) | 0.99% | -1.13% | -0.27% | 0.25% | -0.92% | 3.45% |
EPS (Basic) | -0.28 | -0.31 | -0.17 | -0.40 | -0.11 | 0.00 |
EPS (Diluted) | -0.28 | -0.31 | -0.17 | -0.40 | -0.11 | 0.00 |
Free Cash Flow | 52.95 | 19.81 | -24.49 | -0.43 | 31.04 | 148.45 |
Free Cash Flow Per Share | 0.03 | 0.01 | -0.01 | - | 0.02 | 0.07 |
Gross Margin | -8.91% | -9.84% | -8.84% | 21.72% | 21.45% | 23.57% |
Operating Margin | -39.10% | -52.75% | -51.94% | -41.97% | -18.86% | -4.45% |
Profit Margin | -98.42% | -118.96% | -53.86% | -157.97% | -36.36% | 0.44% |
Free Cash Flow Margin | 9.28% | 3.80% | -3.84% | -0.08% | 5.34% | 20.41% |
EBITDA | -160.79 | -210.97 | -265.24 | -135.21 | -32.43 | 50.12 |
EBITDA Margin | -28.18% | -40.46% | -41.54% | -26.72% | -5.58% | 6.89% |
D&A For EBITDA | 62.31 | 64.07 | 66.42 | 77.16 | 77.14 | 82.47 |
EBIT | -223.11 | -275.04 | -331.66 | -212.37 | -109.57 | -32.35 |
EBIT Margin | -39.10% | -52.75% | -51.94% | -41.97% | -18.86% | -4.45% |
Effective Tax Rate | - | - | - | - | - | 65.66% |
Revenue as Reported | 570.62 | 521.39 | 638.56 | 505.97 | 581.06 | 727.47 |
Advertising Expenses | - | 1.81 | 1.17 | 2.13 | 3.34 | 1.5 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.